Email Updates

Search form

You are here

15 December 2017 VOLUME 18 ISSUE 50

Media Coverage

  • The Global Fund to Fight HIV/AIDS, Malaria and Tuberculosis on Friday released 380 million US dollars to Kenya's ministry of health and partners to support the war against the three infectious diseases that are leading cause of deaths in the East African Nation.

    December 15, 2017
    General
    Xinhua
  • Students living with HIV/AIDS have decried stigma in schools where peers give them funny names and teachers using them as examples during reproductive health classes.

    December 14, 2017
    General
    Observer
  • The past year brought no major breakthroughs in the search for an HIV cure, but a growing understanding of how the virus hides in the body is bringing people closer to strategies for long-term remission, researchers and advocates said at the 2017 HIV Cure Summit.

    December 14, 2017
    Bay Area Reporter
  • An app that allows people to get PrEP prescriptions via their cellphones may expand access to the HIV prevention drug. PlushCare is an app that is available for iOS and Android phones. Recently, the app expanded to 31 states, including California. There are plans to role the app out into the remaining states soon.

    December 14, 2017
    Bay Area Reporter
  • The stigma which cloaks HIV still prevents people from getting regular sexual health tests and seeking treatment following a positive diagnosis. There are also vulnerable social groups in Scotland who are disproportionately affected by HIV.

    December 14, 2017
    BCC Scotland
  • Progress on HIV. The long, slow global fight against HIV and AIDS has reached a promising new milestone – more than half of the 36.7 million people living with HIV worldwide now receive anti-viral treatment, according to the Joint United Nations Program on HIV/AIDS.

    December 14, 2017
    USA Today
  • As abusers of prescription painkillers turn to injection drugs, experts worry the opioid epidemic could result in HIV outbreaks across the United States.

    December 13, 2017
    General
    Circa
  • Researchers are continuously sounding the alarm that people with HIV, who have an elevated risk of cardiovascular disease (CVD) as it is, are prescribed statins at a troublingly low rate, Medscape reports. A new study of people with CVD risk factors found that those with HIV were less likely to be prescribed a statin or aspirin than those without the virus.

    December 13, 2017
    POZ
  • How exactly does posting the hashtag deter HIV transmission? What theory can establish the correlation between the two remote variables- posting the hashtag and then stop HIV?

    December 13, 2017
    General
    SunStar
  • The International Partnership for Microbicides, or IPM, announced the launch of a phase 1 clinical trial that will evaluate a vaginal ring that slowly releases the non-nucleoside reverse transcriptase inhibitor dapivirine over 3 months to prevent HIV infection in women. The ring builds on similar technology used for IPM’s monthly dapivirine ring, which is the first long-acting, self-initiated HIV prevention method that has shown in two phase 3 trials to safely reduce the risk for infection among sexually active women, according to a press release.

    December 13, 2017
    Healio
  • Brazil is the first country in Latin America, and among the first in the developing world, to adopt the pill Truvada, under a program known as PrEP, short for pre-exposure prophylaxis, as an integral part of its preventive health care policy. The blue pill — which drastically reduces the risk of contracting the virus when taken daily — will be made available at no cost to eligible Brazilians at 35 public health clinics in 22 cities during an inaugural phase of the program.

    December 12, 2017
    New York Times
  • Australia’s opposition Labor Party has warned that the country is failing to meet targets for tackling the HIV crisis – as it announced a new funding plan. Under the plans, people at high-risk of HIV would be given cheaper access to breakthrough preventative medicine. The $53 million plan would also expand state trials of PrEP and increase funding for HIV organisations.

    December 11, 2017
    General
    Pink News
  • There is no one single reason rates of HIV/AIDS infection are so high in the region, but rather a convergence of factors—including racism, misogyny, homophobia, and HIV stigmatization—that reflect the systemic inequality in our society.

    December 11, 2017
    General
    Fortune
  • For a quarter century—and in earnest over the past decade—scientists have sought to develop HIV-preventing, antiretroviral (ARV)-infused products known as microbicides that would be inserted into the vagina in the form of sponges, gels, creams, rings or suppositories or into the rectum through enemas, gels, creams or lubricants.

    December 8, 2017
    POZ

Published Research